These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
421 related items for PubMed ID: 18080507
1. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab]. Miztani M, Noda T, Umino A, Tanigawa M, Taniguchi M, Tamaki S, Tsuji K. Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507 [Abstract] [Full Text] [Related]
2. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab. Bennett M, Schechter GP. Semin Hematol; 2010 Apr; 47(2):143-7. PubMed ID: 20350661 [Abstract] [Full Text] [Related]
3. [Splenic marginal zone lymphoma associated with antiphospholipid antibodies]. Yokoi T, Mori S, Sugimoto H, Komiyama Y, Uemura Y, Tanijiri R, Nakai K, Matsumoto N, Zen K, Amakawa R, Kishimoto Y, Ieko M, Takahashi H, Fukuhara S. Rinsho Ketsueki; 2004 Oct; 45(10):1095-9. PubMed ID: 15553043 [Abstract] [Full Text] [Related]
4. [Splenic marginal zone B-cell lymphoma with bilateral renal invasion after splenectomy]. Hoshino T, Iriuchijima H, Ogawa Y, Irisawa H, Jinbo T. Rinsho Ketsueki; 2008 Jan; 49(1):35-9. PubMed ID: 18277594 [Abstract] [Full Text] [Related]
5. Activity of rituximab monotherapy in refractory splenic marginal zone lymphoma complicated with autoimmune hemolytic anemia. Fabbri A, Gozzetti A, Lazzi S, Lenoci M, D'Amuri A, Leoncini L, Lauria F. Clin Lymphoma Myeloma; 2006 May; 6(6):496-9. PubMed ID: 16796783 [Abstract] [Full Text] [Related]
6. Splenic marginal zone lymphoma with or without villous lymphocytes. Hematologic findings and outcomes in a series of 57 patients. Iannitto E, Ambrosetti A, Ammatuna E, Colosio M, Florena AM, Tripodo C, Minardi V, Calvaruso G, Mitra ME, Pizzolo G, Menestrina F, Franco V. Cancer; 2004 Nov 01; 101(9):2050-7. PubMed ID: 15389479 [Abstract] [Full Text] [Related]
7. Case records of the Massachusetts General Hospital. Case 39-2008. A 51-year-old woman with splenomegaly and anemia. Abramson JS, Chatterji M, Rahemtullah A. N Engl J Med; 2008 Dec 18; 359(25):2707-18. PubMed ID: 19092156 [No Abstract] [Full Text] [Related]
8. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma. Gebhart J, Lechner K, Skrabs C, Sliwa T, Müldür E, Ludwig H, Nösslinger T, Vanura K, Stamatopoulos K, Simonitsch-Klupp I, Chott A, Quehenberger P, Mitterbauer-Hohendanner G, Pabinger I, Jäger U, Geissler K. Thromb Res; 2014 Nov 18; 134(5):980-4. PubMed ID: 25201005 [Abstract] [Full Text] [Related]
9. Classical Hodgkin lymphoma concurrently evolving in a patient with marginal zone B-cell lymphoma of the spleen. Harada S, Kalla H, Balasubramanian M, Brodsky I, Gladstone D, Hou JS. Ann Diagn Pathol; 2008 Jun 18; 12(3):212-6. PubMed ID: 18486899 [Abstract] [Full Text] [Related]
10. Splenectomy--a therapeutic option in splenic marginal zone cell lymphoma. Vlădăreanu AM, Onisâi M, Ciufu C, Bumbea H, Cîşleanu D, Voican I, Nicolescu A, Radeşi S, Vintilescu A, Băluţă C, Dobrea C, Savlovschi C, Grecu L, Serban D, Serafim G. Rom J Intern Med; 2009 Jun 18; 47(2):191-9. PubMed ID: 20067170 [Abstract] [Full Text] [Related]
11. A case of splenic lymphoma with marked diffuse nodular fibrosis and calcification, complicated with severe autoimmune hemolytic anemia. Yamazaki K. J Submicrosc Cytol Pathol; 2003 Jan 18; 35(1):17-23. PubMed ID: 12762647 [Abstract] [Full Text] [Related]
12. [Successful treatment with rituximab in a patient with splenic marginal zone B-cell lymphoma accompanied by cold agglutinin disease]. Yasuyama M, Kawauchi K, Otsuka K, Tamura H, Fujibayashi M. Nihon Ronen Igakkai Zasshi; 2014 Jan 18; 51(6):569-75. PubMed ID: 25749330 [Abstract] [Full Text] [Related]
13. [Successful treatment of splenic lymphoma with villous lymphocytes by rituximab and laparoscopic splenectomy]. Fujita T, Asagoe K, Sakoda H. Rinsho Ketsueki; 2003 Apr 18; 44(4):249-53. PubMed ID: 12784658 [Abstract] [Full Text] [Related]
14. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era. Perrone S, D'Elia GM, Annechini G, Ferretti A, Tosti ME, Foà R, Pulsoni A. Leuk Res; 2016 May 18; 44():53-60. PubMed ID: 27030961 [Abstract] [Full Text] [Related]
15. [Splenic marginal zone lymphoma complicated by cold agglutinin disease]. Ochi K, Yokoyama K, Ohno N, Ota Y, Tojo A. Rinsho Ketsueki; 2017 May 18; 58(2):132-137. PubMed ID: 28321090 [Abstract] [Full Text] [Related]
16. Primary splenic marginal zone lymphoma with florid granulomatous reaction--a case report and review of literature. Manipadam MT, Viswabandya A, Srivastava A. Pathol Res Pract; 2007 May 18; 203(4):239-43. PubMed ID: 17398014 [Abstract] [Full Text] [Related]
17. Autoimmune hemolytic anemia as presenting manifestation of primary splenic anaplastic large cell lymphoma. Köksal Y, Calişkan U, Uçar C, Erekul S, Ilerisoy Yakut Z. Turk J Pediatr; 2006 May 18; 48(4):354-6. PubMed ID: 17290572 [Abstract] [Full Text] [Related]
18. Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia. Xing KH, Kahlon A, Skinnider BF, Connors JM, Gascoyne RD, Sehn LH, Savage KJ, Slack GW, Shenkier TN, Klasa R, Gerrie AS, Villa D. Br J Haematol; 2015 May 18; 169(4):520-7. PubMed ID: 25854936 [Abstract] [Full Text] [Related]
19. Composite splenic marginal zone lymphoma and classic Hodgkin lymphoma -- an unusual combination. Elmahy H, Hawley I, Beard J. Int J Lab Hematol; 2007 Dec 18; 29(6):461-3. PubMed ID: 17988302 [Abstract] [Full Text] [Related]
20. Rituximab monotherapy for splenic marginal zone lymphoma. Bennett M, Sharma K, Yegena S, Gavish I, Dave HP, Schechter GP. Haematologica; 2005 Jun 18; 90(6):856-8. PubMed ID: 15951303 [Abstract] [Full Text] [Related] Page: [Next] [New Search]